ConcertAI CEO Jeff Elton (left) and David Spetzler, president of Caris Life Sciences [Photo: ConcertAI]
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
Leading tech companies with a stake in North Texas are helping to shape the future with emerging technologies predicted to transform the world in 2023 and beyond. Clockwise from left: Flytrex and Brinker, Toyota and Google Cloud, Waymo, Texas Instruments, Bell, and Siemens Digital Industries Software. [Courtesy photos]
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients....
Form Bio, named as one of eight Rising Stars to be honored at iC3 2023, announced its launch at the last year's summit. [Photo: John Davidson/Form Bio]
From right: DRC's Jorge Varela (far right) moderated a panel of industry experts including biotech C-level executive Hua Tu, Health Wildcatters CEO and co-founder Hubert Zajicek, and LH Capital Director Matt Crommett.